Bath & Body Works Surges on Stock Recommendation; Klarna Drops on Guidance | Stock Movers

Klarna's shares fell in premarket trading after the payments company reported full-year revenue and gross merchandise value guidance below analyst expectations, citing foreign exchange pressures and volumes in Germany, though it reported a profit beat for the second consecutive quarter. Amylyx Pharmaceuticals shares rose as much as 54% after the drug developer said a late-stage trial of its experimental treatment for low blood sugar following bariatric surgery met its primary endpoint. Citigroup analyst Paul Lejuez raised Bath & Body Works to buy from neutral, citing a favorable risk-to-reward outlook, and the stock surged ahead of the opening bell ahead of earnings scheduled for next week.

Next story